Literature DB >> 19287996

Crosstalk between adenosine receptor (A2A isoform) and ERalpha mediates ethanol action in MCF-7 breast cancer cells.

Nicolas Etique1, Isabelle Grillier-Vuissoz, Julie Lecomte, Stephane Flament.   

Abstract

Alcohol consumption increases the risk of breast cancer but the underlying mechanisms are not well understood. We have shown previously that ethanol activates ER signalling pathway in a cAMP/PKA-mediated ligand-independent manner. Since the activation of A2A adenosine receptor (A2AAR) by ethanol has been reported in other cell types, here we tested if cross-talk between this Gs-coupled receptor and ERalpha could be involved in ethanol effects in breast cancer cells. Our study shows that A2AAR is expressed and functional in the hormone-dependent breast cancer cell line MCF-7. Interestingly, activation of this receptor by the selective agonist CGS21680 stimulates the transcription of progesterone receptor, a well known estrogen target gene. CGS21680 also stimulates the pEREtkLuc reporter activity in transfected MCF-7 cells, an effect antagonized by the antiestrogen ICI182,780. Moreover, CGS21680 stimulates the proliferation of MCF-7 cells similarly to E2. Finally, the A2AAR antagonist MSX-3 inhibits the ethanol-induced activation of ERalpha signalling pathway. These results demonstrate cross-talk between A2AAR and ERalpha that is involved in ethanol action. This could open new perspectives for the therapy of estrogen-dependent breast cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19287996     DOI: 10.3892/or_00000311

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  18 in total

1.  Adenosine A2A and A2B receptor expression in neuroendocrine tumours: potential targets for therapy.

Authors:  A Kalhan; B Gharibi; M Vazquez; B Jasani; J Neal; M Kidd; I M Modlin; R Pfragner; D A Rees; J Ham
Journal:  Purinergic Signal       Date:  2011-11-27       Impact factor: 3.765

2.  Estrogen-dependent hypersensitivity to diabetes-evoked cardiac autonomic dysregulation: Role of hypothalamic neuroinflammation.

Authors:  Mohamed A Fouda; Korin E Leffler; Abdel A Abdel-Rahman
Journal:  Life Sci       Date:  2020-03-31       Impact factor: 5.037

Review 3.  Targeting immunosuppressive adenosine in cancer.

Authors:  Dipti Vijayan; Arabella Young; Michele W L Teng; Mark J Smyth
Journal:  Nat Rev Cancer       Date:  2017-10-23       Impact factor: 60.716

Review 4.  Immunity, inflammation and cancer: a leading role for adenosine.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Nat Rev Cancer       Date:  2013-11-14       Impact factor: 60.716

Review 5.  Alcohol drinking and mammary cancer: Pathogenesis and potential dietary preventive alternatives.

Authors:  Gerardo Daniel Castro; José A Castro
Journal:  World J Clin Oncol       Date:  2014-10-10

6.  Increased Extracellular Adenosine in Radiotherapy-Resistant Breast Cancer Cells Enhances Tumor Progression through A2AR-Akt-β-Catenin Signaling.

Authors:  Hana Jin; Jong-Sil Lee; Dong-Chul Kim; Young-Shin Ko; Gyeong-Won Lee; Hye-Jung Kim
Journal:  Cancers (Basel)       Date:  2021-04-27       Impact factor: 6.639

Review 7.  Extracellular purines, purinergic receptors and tumor growth.

Authors:  F Di Virgilio; E Adinolfi
Journal:  Oncogene       Date:  2016-06-20       Impact factor: 9.867

Review 8.  Adenosine receptors: expression, function and regulation.

Authors:  Sandeep Sheth; Rafael Brito; Debashree Mukherjea; Leonard P Rybak; Vickram Ramkumar
Journal:  Int J Mol Sci       Date:  2014-01-28       Impact factor: 5.923

9.  Long-term exposure of MCF-12A normal human breast epithelial cells to ethanol induces epithelial mesenchymal transition and oncogenic features.

Authors:  Robert Gelfand; Dolores Vernet; Kevin Bruhn; Jaydutt Vadgama; Nestor F Gonzalez-Cadavid
Journal:  Int J Oncol       Date:  2016-03-29       Impact factor: 5.650

10.  Long-term exposure of MCF-7 breast cancer cells to ethanol stimulates oncogenic features.

Authors:  Robert Gelfand; Dolores Vernet; Kevin W Bruhn; Suren Sarkissyan; David Heber; Jaydutt V Vadgama; Nestor F Gonzalez-Cadavid
Journal:  Int J Oncol       Date:  2016-12-09       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.